Ad imageAd image

Addressing infrastructure gaps to accelerate the scaleup of U.S. biomanufacturing

While the U.S. is a global leader in bioresearch and innovation, the country faces a critical shortage in domestic pilot and intermediate-scale industrial biomanufacturing infrastructure, leading companies to look overseas for facilities to scale their processes from lab to commercial production. Hear how BioMADE and its partners are working to fill that gap, with updates on facilities in Minnesota and California and plans to establish a nationwide network of world-class biomanufacturing infrastructure.

Featuring: Chad Pastor, Senior Manufacturing Development Lead, BioMADE

This presentation was recorded at Bio Innovations Midwest on 15-16 September 2025. Find out more about the event, the only commercially focused event for the industrial biomanufacturing community in North America, here: https://www.bioinnovationsmidwest.com/

Share This Article